News | Magnetic Resonance Imaging (MRI) | November 02, 2016

Using MRI brain scans to assess shrinkage of hippocampus could help predict dementia with Lewy bodies versus Alzheimer’s disease

MRI, brain scans, shrinkage, dementia with Lewy bodies, Alzheimer's disease, Neurology journal study

November 2, 2016 — Lack of shrinkage in the area of the brain responsible for memory may be a sign people with thinking and memory problems may go on to develop dementia with Lewy bodies rather than Alzheimer’s disease, according to a new study. Shrinkage in this hippocampus area of the brain is an early sign of Alzheimer’s disease.

The study was published in the Nov. 2, 2016, online issue of Neurology, a medical journal of the American Academy of Neurology.

Dementia with Lewy bodies is a common form of dementia. Because it has many symptoms in common with Alzheimer’s and Parkinson’s disease, it can be difficult to diagnose. It can include movement problems, sleep disorders and hallucinations.

“Being able to identify people who are at risk for dementia with Lewy bodies is important so they can receive the correct treatments early on,” said study author Kejal Kantarci, M.D., MS, of the Mayo Clinic in Rochester, Minn., and a member of the American Academy of Neurology. “Early diagnosis also helps doctors know what drugs to avoid — up to 50 percent of people with dementia with Lewy bodies have severe reactions to antipsychotic drugs.”

For the study, 160 people with thinking and memory problems, called mild cognitive impairment, had brain magnetic resonance imaging (MRI) scans at the start of the study to measure the size of the hippocampus. They also had yearly tests for an average of two years. During that time, 61 people, or 38 percent, developed Alzheimer’s disease and 20 people, or 13 percent, progressed to probable dementia with Lewy bodies. It is called probable dementia with Lewy bodies because the disease can be diagnosed definitively only by an autopsy after death.

The people who had no shrinkage in the hippocampus were 5.8 times more likely to develop probable dementia with Lewy bodies than those who had hippocampal shrinkage. A total of 17 out of the 20, or 85 percent, of people who developed dementia with Lewy bodies had a normal hippocampus volume; while 37 of the 61, or 61 percent, of people who developed Alzheimer’s disease had shrinkage in the hippocampus.

The relationship was even stronger when researchers looked only at people whose thinking problems did not include memory issues. Dementia with Lewy bodies does not always affect memory; thinking skills that are affected usually include attention, problem solving and the ability to interpret visual information.

Kantarci noted that diagnosis of dementia with Lewy bodies and Alzheimer’s disease can also be difficult because some people have signs of both diseases in their brains. She said this research should be confirmed with studies that use autopsies for final diagnoses.

The study was supported by the National Institutes of Health, Mangurian Foundation and Robert H. and Clarice Smith and Abigail Van Buren Alzheimer’s Disease Research Program.

For more information: www.neurology.org

Related Content

News | Women's Health

October 11, 2021 — Electrical engineering professor Magda El-Shenawee’s effort to develop a more accurate and less ...

Time October 11, 2021
arrow
News | Radiation Therapy

October 7, 2021 — ViewRay, Inc. announced that the company has received acceptance from the FDA on their recent ...

Time October 07, 2021
arrow
Feature | Cardiac Imaging

October 6, 2021 – A new study published in Radiology: Cardiothoracic Imaging on cardiac imaging trends over a decade ...

Time October 06, 2021
arrow
News | Radiology Business

September 27, 2021 — Esaote, an Italian company leader in the biomedical equipment sector – ultrasound, MRI and software ...

Time September 27, 2021
arrow
News | Prostate Cancer

September 24, 2021 — Scientists have identified two subtypes of metastatic prostate cancer that respond differently to ...

Time September 24, 2021
arrow
News | Cardiac Imaging

September 22, 2021 — Test selection should be a shared decision between patient and physician rather than directed by ...

Time September 23, 2021
arrow
News | Women's Health

September 22, 2021 — Radiation therapy is an effective and widely used treatment for breast cancer. While the benefits ...

Time September 22, 2021
arrow
News | Magnetic Resonance Imaging (MRI)

September 20, 2021 — Gadolinium-based contrast agents, the gold standard in magnetic resonance imaging (MRI) to ...

Time September 20, 2021
arrow
News | Contrast Media Injectors

September 16, 2021 — FDB (First Databank), a leading provider of drug and medical device knowledge that helps healthcare ...

Time September 16, 2021
arrow
News | Lung Imaging

September 15, 2021 — Revised guidelines for lung cancer screening eligibility are perpetuating disparities for racial ...

Time September 15, 2021
arrow
Subscribe Now